GranuFlo manufacturer receives second FDA warning letter

Fresenius Medical Care, manufacturer of recalled GranuFlo and NaturaLyte dialysis acid concentrates, has received a second warning letter from the U.S. Food and Drug Administration. The first letter pertained to quality control at a facility in India, while the second pertains to quality at a facility in Puerto Rico.

Read more about the Fresenius warning letter…

0 Responses to “GranuFlo manufacturer receives second FDA warning letter”

  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101


Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.

%d bloggers like this: